reconstituting bpc 157/tb 500 BPC-157 vs TB-500 UK BPC-157 Research Peptide Set |

A common research protocol: BPC-157: 250500 mcg daily (subcutaneous near injury) TB-500: 2.5 mg twice weekly (subcutaneous) Duration: 48 weeks The Bottom Line Neither peptide is universally "better" they excel in different contexts and work through different mechanisms

Stem Cells 27(10):24052413 Zhao Y et al (2010) Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro

In healthy tissue, the peptide maintains NO homeostasis by modestly increasing endothelial NOS (eNOS) for beneficial vasodilation while suppressing inducible NOS (iNOS) that drives pathological inflammation

The present study, for the first time, demonstrates an underlying mechanism for the activation of eNOS by BPC 157 on stimulating the Cav-1 phosphorylation and reducing the binding of eNOS to Cav-1

Just 100 units equals 1 milliliter